Case Reports
doi: 10.3109/08880018.2011.599051.
Epub 2011 Aug 29.
The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level
- PMID: 21875319
- DOI: 10.3109/08880018.2011.599051
Item in Clipboard
Case Reports
The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level
Pediatr Hematol Oncol.
2011 Nov.
No abstract available
Similar articles
-
Anti-Rh(c), "little c," isoimmunization: the role of rHuEpo in preventing late anemia.J Pediatr Hematol Oncol. 2013 Aug;35(6):e269-71. doi: 10.1097/MPH.0b013e318271f5b0. J Pediatr Hematol Oncol. 2013. PMID: 23073047
-
Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.Pediatrics. 1992 Nov;90(5):678-80. Pediatrics. 1992. PMID: 1408538
-
Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion.Fetal Diagn Ther. 2002 Jan-Feb;17(1):22-4. doi: 10.1159/000048000. Fetal Diagn Ther. 2002. PMID: 11803211
-
Management of neonatal Rh disease.Clin Perinatol. 1995 Sep;22(3):561-92. Clin Perinatol. 1995. PMID: 8521682 Review.
-
Hematopoietic growth factors: Part II.Neonatal Netw. 1996 Oct;15(7):25-8. Neonatal Netw. 1996. PMID: 9035641 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
